The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform Encephalopathies
NEJM 335:924-930, 9631996., Hsich,G.,et al, 1996
Diagnosis of Creutzfeldt-Jakob Disease in Two-Dimensional Gel Electrophoresis of Cerebrospinal Fluid
Lancet 348:846-849, Zerr,I.,et al, 1996
The Babinski Sign:100 Years On
BMJ 313:1029-1030, Ditunno,J.F.&Bell,R., 1996
Adverse Cerebral Outcomes After Coronary Bypass Surgery
NEJM 335:1857-1863, Roach,G.W.,et al, 1996
Clinical and Genetic Abnormalities in Patients with Friedreich's Ataxia
NEJM 335:1169-1175, 12221996., Durr,A.,et al, 1996
Low-Dose Oral Methotrexate in Chronic Progressive Multiple Sclerosis:Analyses of Serial MRIs
Neurol 47:1153-1157, Goodkin,D.E.,et al, 1996
X-Linked Malformation of Neuronal Migration
Neurol 47:331-339, Dobyns,W.B.,et al, 1996
Natural Evolution of Late Shiplash Syndrome Outside the Medicolegal Context
Lancet 347:1207-1211, Schrader,H.,et al, 1996
New Antiepileptic Drugs
NEJM 334:1583-1590, Dichter,M.A.&Brodie,M.J., 1996
Temporal Lobectomy for Refractory Epilepsy
JAMA 276:470-475, Sperling,M.R.,et al, 1996
Practice Parameter:The Neurodiagnostic Evaluation of the Child with First Simple Febrile Seizure
Pediatrics 97:769-772, Bergman,D.A.,et al, 1996
Reversible Parkinsonism and Cognitive Impairment with Chronic Valproate Use
Neurol 47:626-635, Armon,C.,et al, 1996
Startle Provoked Epileptic Seizures:Features in 19 Patients
JNNP 61:151-156, Manford,M.R.A.,et al, 1996
The Use of Parenteral Antiepileptic Drugs & The Role of Fosphenytoin
(Suppl Editor) , Neurol 46:S1-S2896., Wilder,B.J., 1996
Accidental Injury is a Serious Risk in Children with Typical Absence Epilepsy
Arch Neurol 53:929-932, Wirrell,E.C.,et al, 1996
Progressive Encephalomyelitis with Rigidity Responsive to Plasmapheresis and Immunosuppression
Ann Neurol 40:451-453, Fogan,L., 1996
Reversible Dementia in Idiopathic Hypoparathyroidism Associated with Normocalcemia
Neurol 47:474-476, Stuerenberg,H.J.,et al, 1996
Pseudotumor Associated with CNS Lymphoma
J Neuro-Ophthalmol 16:208-211, Hudson,H.L.,et al, 1996
Maternal Phenylketonuria:Magnetic Resonance Imaging of the Brain in Offspring
J Pediatr 128:770-775, Levy,H.L.,et al, 1996
Leigh Syndrome:Clinical Features and Biochemical DNA Abnormalities
Ann Neurol 39:343-351, Rahman,S.,et al, 1996
Cranial Neuropathies and Liver Failure Due to Hepatitis A
Neurol 46:1774-1775, Varona,L.,et al, 1996
Twelfth-Nerve Palsy:Analysis of 100 Cases
Arch Neurol 53:561-566, Keane,J.R., 1996
Multifocal Motor Neuropathy
JNNP 60:599-603, Nobile-Orazio,E., 1996
Phenotypic Heterogen in Hered Neurop with Liability to Press Palsies Assoc with Chromosome 17p11. 2-12 Delet
Neurol 46:1133-1137, Pareyson,D.,et al, 1996
Intelligence and the X Chromosome
Lancet 347:1814-1815, Turner,G., 1996
Intellectual Impairment in Children Exposed to Polychlorinated Biphenyls in Utero
NEJM 335:783-789, Jacobson,J.L.,et al, 1996
Clinicopath Study of Paraneoplastic Brainstem Encephalitis and Ophthalmoparesis
J Neuro-Ophthalmol 16:44-48, Crino,P.B.,et al, 1996
Motor Neuron Disease:A Paraneoplastic Process Associated with Anti-Hu Antibody and Small-Cell Lung Carcinoma
Ann Neurol 40:112-116, Verma,A.,et al, 1996
Falls and Urinary Incontinence in a 66-Year Old Woman
Lancet 347:1738, Yusuf,S.W.,et al, 1996
Opsoclonus
Semin Neurol 16:21-26, Averbuch-Heller,L.&Remler,B., 1996
Acute Paresis of Extraocular Muscles Associated with IgG Anti-GQ Antibody
Ann Neurol 39:668-672, Yuki,N., 1996
Frequency of Dementia in Parkinson Disease
Arch Neurol 42:428-431, Aarsland,D.,et al, 1996
Multicenter, Placebo-Controlled Trial of Cabergoline Taken Once Daily in the Treatment of Parkinson's Disease
Neurol 46:1062-1065, Hutton,J.T.,et al, 1996
Diffuse Lewy Body Disease:Clinical Features in Nine Cases without Coexistent Alzheimer's Disease
JNNP 60:531-538, Hely,M.A.,et al, 1996
Double-Blind Comparison of Cabergoline & Bromocriptine in Parkinson's Disease Pts with Motor Fluctuations
Neurol 47:785-788, Inzelberg,R.,et al, 1996
Development of General Weakness in a Patient with Amyotrophic Lateral Sclerosis after Focal Botulinum Toxin Injection
Neurol 46:845-846, Mezaki,T.,et al, 1996
Chronic Inflammatory Demyelinating Polyradiculoneuropathy:Unusual Clinical Features and Therapeutic Responses
Neurol 46:1206-1212, Midroni,G.&Dyck,P.J., 1996
Critical Illness Myopathy and Neuropathy
Lancet 347:1579-1582, Latronico,N.,et al, 1996
Clinicopath Conf
Tangier Disease, Case 16-1996, NEJM 334:1389-1394996., , 1996
Motor Neuropathy Due to Docetaxel and Paclitaxel
Neurol 47:115-118, Freilich,R.J.,et al, 1996
Ten Steps in Characterizing and Diagnosing Patients with Peripheral Neuropathy
Neurol 47:10-17, Dyck,P.J.,et al, 1996
Familial Hemiplegic Migraine, Nystagmus and Cerebellar Atrophy
Ann Neurol 39:100-106, Elliott,M.A.,et al, 1996
Dementia in a 58-year-old Woman
Lancet 347:236, Sellal,F.,et al, 1996
Liver Function Disturbances in Guillain-Barre Syndrome:A Prospective Longitudinal Study in 100 Patients
Neurol 46:96-100, Oomes,P.G.,et al, 1996
Pilot Trial of Immunoglobulin Versus Plasma Exchange in Patients with Guillain-Barre Syndrome
Neurol 46:100-103, Bril,V.,et al, 1996
Ocular Manifestations of AIDS
JAMA 275:142-144, 1491996., Whitcup,S.M., 1996
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Acute Rectus Muscle Palsy in Children as a Result of Orbital Myositis
J Pediatr 128:230-233, Pollard,F.,et al, 1996
Subarachnoid Fluid Collections:A Cause of Macrocrania in Preterm Infants
J Pediatr 128:234-236, AlSaedi,S.A.,et al, 1996
Peripheral Neuropathy Secondary to Docetaxel (Taxotere)
Neurol 46:108-111, 21996., New,P.Z.,et al, 1996